CYTEK BIOSCIENCES DL-,001

CYTEK BIOSCIENCES DL-,001

Share · US23285D1090 · CTKB · A3CVW1 (XNAS)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of CYTEK BIOSCIENCES DL-,001
Analyst Grade Summary
gauge-img
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
0
3
1
1
0
No Price
29.04.2026 05:27
Current Prices from CYTEK BIOSCIENCES DL-,001
ExchangeTickerCurrencyLast TradePriceDaily Change
XDQU: Quotrix
Quotrix
CBIRSD90.DUSD
EUR
29.04.2026 05:27
3,92 EUR
-
XNAS: NASDAQ
NASDAQ
CTKB
USD
28.04.2026 20:00
4,57 USD
0,11 USD
+2,47 %
IEXG: IEX
IEX
CTKB
USD
28.04.2026 19:59
4,59 USD
0,13 USD
+2,80 %
XDUS: Düsseldorf
Düsseldorf
CBIRSD90.DUSB
EUR
28.04.2026 17:32
3,90 EUR
-
ESG Risk Rating
B- Good
Share Float & Liquidity
Free Float 91,55 %
Shares Float 117,69 M
Shares Outstanding 128,55 M
Company Profile for CYTEK BIOSCIENCES DL-,001 Share
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system, which leverages full spectrum profiling technology to further broaden potential applications across cell analysis. The company also provides reagents and kits, including cFluor reagents, which are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, which are automated plate loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific region; and through distributors or sales agents in European, Latin American, the Middle Eastern, and the Asia-Pacific countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.

Company Data

Name CYTEK BIOSCIENCES DL-,001
Company Cytek Biosciences, Inc.
Symbol CTKB
Website https://cytekbio.com
Primary Exchange XNAS Frankfurt
WKN A3CVW1
ISIN US23285D1090
Asset Class Share
Sector Healthcare
Industry Medical - Devices
CEO Wenbin Jiang
Market Capitalization 587 Mio
Country United States of America
Currency EUR
Employees 0,7 T
Address 47215 Lakeview Boulevard, 94538 Fremont
IPO Date 2021-07-23

Ticker Symbols

Name Symbol
Düsseldorf CBIRSD90.DUSB
Frankfurt 8EQ.F
NASDAQ CTKB
Quotrix CBIRSD90.DUSD
More Shares
Investors who hold CYTEK BIOSCIENCES DL-,001 also have the following shares in their portfolio:
NORDLB 2 PH.BD.13/13
NORDLB 2 PH.BD.13/13 Bond
Rydex High Yield Strategy Fund Class A
Rydex High Yield Strategy Fund Class A Fund